ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Kalvista Pharmaceuticals (KALV) Technical (Analysis) Reports Kalvista Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Kalvista Pharmaceuticals (KALV)

Technical Analysis Report for NASDAQ stock KALV Kalvista Pharmaceuticals. Dated: 16 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock KALV Kalvista Pharmaceuticals then click here. or read Experts views on Kalvista Pharmaceuticals or Forecast & share price targets of Kalvista Pharmaceuticals

Kalvista Pharmaceuticals Opened at 14.93 and Closed at: 14.60, which is -2.47% of previous session's close. It moved within a range of 14.44 and 15.14
The session was a Bearish session with an average volume of 1159700, which is 18.52% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 5 days back on short term averages

Support for tomorrow is 14.17 and resistance for tomorrow is 14.87
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 14.31, 14.03 resistance for tomorrow's hourly charts is 15.01, 15.43

10 Day SMA for Kalvista Pharmaceuticals (KALV) is 15.65 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Kalvista Pharmaceuticals (KALV) is 15.59 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Kalvista Pharmaceuticals (KALV) is 14.75 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.65 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Kalvista Pharmaceuticals is 13.25 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Kalvista Pharmaceuticals is at 15.59 and 200 DMA is at 13.25, while 50 DMA and 100 DMA are at 14.75 and 13.65 respectively

Kalvista Pharmaceuticals (KALV) moving average of 20 SMA is at 15.59 and 20 EMA is at 15.49

Kalvista Pharmaceuticals (KALV) moving average of 50 SMA is at 14.75 and 50 EMA is at 14.84

Kalvista Pharmaceuticals (KALV) moving average of 100 SMA is at 13.65 and 100 EMA is at 14.09

Kalvista Pharmaceuticals (KALV) moving average of 200 SMA is at 13.25 and 200 EMA is at 13.4

111 Inc has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in 111 Inc, about 56.62% more returns!

Vertex Pharmaceuticals has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 1.32% more returns!

Riot Blockchain has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Riot Blockchain, about 46.39% more returns!

Radnet Inc has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 2.1% more returns!

Kalvista Pharmaceuticals has performed better than Protagonist Therapeutics in short term. Holding Kalvista Pharmaceuticals could be a better choice for now!

Phibro Animal has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Phibro Animal, about 4.3% more returns!

Omeros Corporation has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Omeros Corporation, about 33.86% more returns!

Masimo Corporation has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Masimo Corporation, about 6.61% more returns!

Kalvista Pharmaceuticals has performed better than Akebia Therapeutics in short term. Holding Kalvista Pharmaceuticals could be a better choice for now!

Biomarin Pharmaceutical has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 7.75% more returns!

Equillium Inc has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Equillium Inc, about 9.15% more returns!

Harrow Health has performed better than Kalvista Pharmaceuticals in short term. You could have earned much better returns by investing in Harrow Health, about 10.17% more returns!

Kalvista Pharmaceuticals has performed better than Inc Research in short term. Holding Kalvista Pharmaceuticals could be a better choice for now!

Kalvista Pharmaceuticals Technical analysis of indicators

Price action analysis of Kalvista Pharmaceuticals (KALV) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Kalvista Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Kalvista Pharmaceuticals in short term but the sell signal is initial and weak.

Kalvista Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Kalvista Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Kalvista Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 15.89 and Kalvista Pharmaceuticals KALV stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Kalvista Pharmaceuticals KALV stock. Volume based technical analysis of Kalvista Pharmaceuticals KALV stock is negative.

Kalvista Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock KALV Kalvista Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And KALV Experts View which covers a lot of information including buying and selling signals

KALV future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Kalvista Pharmaceuticals or View Candle Stick Charts here

Chart Kalvista Pharmaceuticals (KALV)  Technical (Analysis) Reports Kalvista Pharmaceuticals [

Videos related to: Kalvista Pharmaceuticals (KALV) Technical (Analysis) Reports Kalvista Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Kalvista Pharmaceuticals (KALV)  Technical (Analysis) Reports Kalvista Pharmaceuticals [

 

Back to top